How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone?

This publication has 34 references indexed in Scilit:

• Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects
  Nucleic Acids Research, 1997
• Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, andCDKN2C) in childhood rhabdomyosarcoma
  Genes, Chromosomes and Cancer, 1996
• Detection of TP53 gene mutations in human sarcomas
  European Journal Of Cancer, 1995
• Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
  Science, 1994
• Osteosarcoma
  Current Opinion in Oncology, 1993
• A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomas
  Cancer Genetics and Cytogenetics, 1992
• Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.
  Proceedings of the National Academy of Sciences, 1992
• p53 Mutations in Human Cancers
  Science, 1991
• Postradiation Malignant Fibrous Histiocytoma of Bone
  The American Journal of Surgical Pathology, 1986
• Intra- and Extraosseous Malignant Histiocytoma (Malignant Fibrous Xanthoma)
  Radiology, 1972